A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Clinical trial NCT04261712 · TERMINATED
Trial details
- NCT number
- NCT04261712
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2026-06-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.